Oncolytics Biotech (TSX:ONC) Other Long Term Assets : C$0.00 Mil (As of Sep. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Oncolytics Biotech Other Long Term Assets?

Oncolytics Biotech's other long-term assets for the quarter that ended in Sep. 2024 was C$0.00 Mil.

Oncolytics Biotech's quarterly other long-term assets increased from Mar. 2024 (C$0.00 Mil) to Jun. 2024 (C$0.00 Mil) but then stayed the same from Jun. 2024 (C$0.00 Mil) to Sep. 2024 (C$0.00 Mil).

Oncolytics Biotech's annual other long-term assets increased from Dec. 2021 (C$-0.00 Mil) to Dec. 2022 (C$1.00 Mil) but then declined from Dec. 2022 (C$1.00 Mil) to Dec. 2023 (C$-0.00 Mil).

Oncolytics Biotech Other Long Term Assets Historical Data

The historical data trend for Oncolytics Biotech's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncolytics Biotech Other Long Term Assets Chart

Oncolytics Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

1.00

Oncolytics Biotech Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Long Term Assets	Get a 7-Day Free Trial															-	-	-	-	-

Oncolytics Biotech Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Oncolytics Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncolytics Biotech Inc (TSX:ONC) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

ONCY:USA

Address

322 11th Avenue S.W, Suite 804, Calgary, AB, CAN, T2R 0C5

Website

https://www.oncolyticsbiotech.com

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.

Executives

Angela Frances Holtham	Director
Deborah Brown	Director
Bernd Robert Seizinger	Director
Matthew Coffey	Director, Senior Officer
Kirk Look	Senior Officer

Oncolytics Biotech Headlines

No Headlines